Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection
Clinical trial NCT05218070 · UNKNOWN
Trial details
- NCT number
- NCT05218070
- Sponsor
- Eva Pharma
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-06
- Primary completion
- 2022-10-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.